INDEX 



603 



Suprarenal capsules, experimental ex- 

 tirpation, death following, 142 



. - , followed by toxicity of 



blood, 156 



-. . , followed by toxicity of 

 muscles and viscera, 156 



- , organotherapy after, 165- 



168 



, symptoms, 153-158 



, fat-contents, distribution, 285 



. , ferments in, 275 



, functions of, historical account 

 of discoveries, 124-127 



, in relation to muscular 

 fatigue, 295 

 , suppression chronic, 159 



, due to haemorrhage into 

 organ, 159 



, symptom - com- 

 plex, 159 



in man, 158 

 , symptoms, 153-158 

 , hypersecretion, experimental, 



260; see also Hy-peradrenalism 

 , hypertrophy in pseudo-herma- 



phroditism, 269 

 , hypofunction, 261 

 , hypoplastic infantilism of, 158 

 in adder, 298 

 in Batrachians, 299 

 in birds, 299, 300 



, indispensable to life, 17 



in fish, extirpation not fatal, 

 152, 153 



, innervation, physiology of, 260 



in Selachians, 299 

 , lecithin in, 286 



3 lipoids in, 279, 287, 292, 293 



, medulla of, 128, 131 



, experimental extirpation, 

 146-150 



, hyperplasia of chromaffine 

 tissue, 262 

 , quantitative value, 265 



, over-estimated, 265 

 , secretory processes, morph- 

 ology, 252 

 , total aplasia of, 158 



, not homogeneous organs, 127 



of pigs, distillation with hot 

 acetone, 290, 291 



, lipoid substances in, 290, 

 291 



of rabbits, amorphous masses 



in, 284 



, physiology of, 134, 138 

 , portal system, 298, 299 

 in birds, 300 



in reptiles, 299 

 , primary disease, rare, 159 



, reaction to adrenalin, 212 



, reduction in size of, 158 



, relationship to hypophysis, 339 



, secretory process of, 251 



, sound, but with clinical signs 



of Addison's disease, 159, 160 



40 



Suprarenal capsules, stimulation, ex- 

 perimental, 260 

 -3 substitution, 165 

 , transplantation, 168 

 , functional capacity. 171 

 , histological observations, 

 169 



, regression and proliferation 

 of tissue following, 170, 171 

 , site of, 170, 171, 172 

 , successful, 170 



, conditions for, 173 

 , tuberculosis of both, typical 

 feature of Addison's disease, 159. 

 , vascularization of, 298 

 , weight of, increased after cas- 

 tration, 269 



, increase during pregnancy,. 

 269 



in different animals, 269 

 extract, blood-pressure increased 

 bv, how abolished, 157 



in Addison's disease, 168 

 , physiological action of, 173,. 



174 

 , specific action centred in 



adrenal body, 247 

 , toxic action, 175, 176 

 , watery, intravenous injection, 



177; see also Adrenalin 

 organs, accessory, 131, see also- 



Intcrrctial bodies, accessory 

 systems in invertebrates, tables 



illustrating, 135-13? 

 Suprarenin, 178 

 , d, toxic dose, 237 

 , 1, toxic dose, 237 

 , synthetic racemic, 179 

 Sugar in urine, see Glycosnria 

 Surgery, operative, knowledge as to- 

 internal secretions obtained 

 through, 17 

 Sweat glands, action of adrenalin on, 



214 

 , innervation of, 191, 195 



TACHYCARDIA, following administration 



of thyroid extracts, 90 

 Temperature, bodily, modified bv 



action of adrenalin, 226 

 Testicle, cryptorchidic, 393 

 , development of, 366, 369, 371 

 , secretory elements of, 392 

 , watery extract, 21 

 Testicular extract, effects of, 389 



, injection of, effect, 4 

 Tetania parathyropriva, 38, 39, 47 

 Tetany, acute, experimental, 37, 39, 40- 



, milk diet in, 107 



, secondary symptoms following, 



43 



, tuberculosis and, 46 

 , chronic, experimental production, 



43 



, experimental, albuminuria accom- 

 panying, 43 



